The Receptor Activator of Nuclear Factor-κB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism.

MLA

Padagas, J., et al. “The Receptor Activator of Nuclear Factor-ΚB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism.” Calcified Tissue International, vol. 78, no. 1, Jan. 2006, pp. 35–44. EBSCOhost, https://doi.org/10.1007/s00223-005-0161-1.

APA

Padagas, J., Colloton, M., Shalhoub, V., Kostenuik, P., Morony, S., Munyakazi, L., Guo, M., Gianneschi, D., Shatzen, E., Geng, Z., Tan, H.-L., Dunstan, C., Lacey, D., & Martin, D. (2006). The Receptor Activator of Nuclear Factor-κB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism. Calcified Tissue International, 78(1), 35–44. https://doi.org/10.1007/s00223-005-0161-1

Chicago

Padagas, J., M. Colloton, V. Shalhoub, P. Kostenuik, S. Morony, L. Munyakazi, M. Guo, et al. 2006. “The Receptor Activator of Nuclear Factor-ΚB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism.” Calcified Tissue International 78 (1): 35–44. doi:10.1007/s00223-005-0161-1.